

Cover Story
By Matthew Bin Han Ong
In a city that in recent years has come to epitomize the growing racial divide in wealth and health outcomes, Georgetown University’s Lombardi Comprehensive Cancer Center, with help from the Ralph Lauren Corporate Foundation, is establishing a patient navigation, screening, and education center to serve historically marginalized neighborhoods.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years
- After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.” - Trump administration announces “major crackdown” on healthcare fraud
- FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases
















